Vericel (VCEL) Preferred Dividend Payments (2012 - 2013)
Vericel (VCEL) posted Preferred Dividend Payments of $1.3 million for Q1 2013, up 0.64% sequentially from $1.3 million in Q4 2012, and up 337.02% YoY from $289000.0 in Q1 2012.
Powered by 
Analysis
Vericel (VCEL) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
Vericel has reported Preferred Dividend Payments for 2 years, with the latest figure at $1.3 million in Q1 2013.
- Quarterly Preferred Dividend Payments rose 337.02% year-over-year to $1.3 million in Q1 2013, while the trailing twelve-month figure through Jun 2013 was $3.7 million (changed N/A YoY) and the FY2012 annual result came in at $4.0 million, changed N/A from the prior year.
- Preferred Dividend Payments climbed to $1.3 million in Q1 2013 per VCEL's latest filing, from $1.3 million in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $1.3 million in Q1 2013 and troughed at $289000.0 in Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2013 | 1.26 Mn |
| Dec 31, 2012 | 1.26 Mn |
| Sep 30, 2012 | 1.22 Mn |
| Jun 30, 2012 | 1.23 Mn |
| Mar 31, 2012 | 289,000.00 |